Related references
Note: Only part of the references are listed.Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice
Luca De Nicola et al.
JOURNAL OF NEPHROLOGY (2018)
The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling
Jonatan Barrera-Chimal et al.
KIDNEY INTERNATIONAL (2018)
New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention
Patrycjusz Kolodziejczyk et al.
CURRENT DRUG TARGETS (2018)
Aldosterone-induced expression of ENaC-α is associated with activity of p65/p50 in renal epithelial cells
Rongquan Chen et al.
JOURNAL OF NEPHROLOGY (2017)
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology
Vincenzo Bellizzi et al.
JOURNAL OF NEPHROLOGY (2017)
Pharmacokinetics, distribution, and disposition of esaxerenone, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist, in rats and monkeys
Makiko Yamada et al.
XENOBIOTICA (2017)
Aldosterone Target NGAL (Neutrophil Gelatinase-Associated Lipocalin) Is Involved in Cardiac Remodeling After Myocardial Infarction Through NFκB Pathway
Ernesto Martinez-Martinez et al.
HYPERTENSION (2017)
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury-Mediated Chronic Kidney Disease Role of Oxidative Stress
Lionel Lattenist et al.
HYPERTENSION (2017)
Mineralocorticoid receptor antagonists: 60 years of research and development
Peter Kolkhof et al.
JOURNAL OF ENDOCRINOLOGY (2017)
Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1
Jonatan Barrera-Chimal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Renin-angiotensin system blockade: Finerenone
Luis M. Ruilope et al.
NEPHROLOGIE & THERAPEUTIQUE (2017)
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
Jochen Dutzmann et al.
PLOS ONE (2017)
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
Greg H. Tesch et al.
FRONTIERS IN PHARMACOLOGY (2017)
Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury
Nobuhiro Ayuzawa et al.
HYPERTENSION (2016)
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
Andrew S. Bomback
BLOOD PURIFICATION (2016)
Cardiac Tissue Injury and Remodeling Is Dependent Upon MR Regulation of Activation Pathways in Cardiac Tissue Macrophages
Jimmy Z. Shen et al.
ENDOCRINOLOGY (2016)
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
Gerasimos Filippatos et al.
EUROPEAN HEART JOURNAL (2016)
Low glomerular filtration rate and risk of myocardial infarction: A systematic review and meta-analysis
Vishal Vashistha et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists Cause Differential Cardiac Gene Expression in Pressure Overload-induced Cardiac Hypertrophy
Jana Grune et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arena
Murray Epstein
KIDNEY INTERNATIONAL SUPPLEMENTS (2016)
Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology
F. Jaisser et al.
PHARMACOLOGICAL REVIEWS (2016)
CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats
Kiyoshi Arai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Relation of Aortic Valve Calcium to Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort Study)
Marie A. Guerraty et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Underprescription of Renin-Angiotensin System Blockers in Moderate to Severe Chronic Kidney Disease
Shayan Shirazian et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2015)
Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist
Kiyoshi Arai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats
Kiyoshi Arai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1
Larbi Amazit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Intersection of cardiovascular disease and kidney disease: atrial fibrillation
Nisha Bansal et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: An emerging paradigm in diabetic nephropathy A systematic review
Thomas A. Mavrakanas et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)
Emerging drugs for chronic kidney disease
Sergio Stefoni et al.
EXPERT OPINION ON EMERGING DRUGS (2014)
Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
Peter Kolkhof et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
Aldosterone synthase inhibitors in cardiovascular and renal diseases
Pawel Namsolleck et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Incidence and Predictors of Postoperative Atrial Fibrillation in Kidney Transplant Recipients
Gaetano La Manna et al.
TRANSPLANTATION (2013)
Aldosterone and cardiovascular disease: the heart of the matter
B. Julie He et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Oxidative Stress Causes Mineralocorticoid Receptor Activation in Rat Cardiomyocytes Role of Small GTPase Rac1
Miki Nagase et al.
HYPERTENSION (2012)
Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms
Linda Shavit et al.
KIDNEY INTERNATIONAL (2012)
Deletion of Cardiomyocyte Mineralocorticoid Receptor Ameliorates Adverse Remodeling After Myocardial Infarction
Daniela Fraccarollo et al.
CIRCULATION (2011)
Effect of eplerenone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric chronic hemodialysis patients - a pilot study
L. Shavit et al.
CLINICAL NEPHROLOGY (2011)
Minireview: Aldosterone and Mineralocorticoid Receptors: Past, Present, and Future
John W. Funder
ENDOCRINOLOGY (2010)
Aldosterone and Mineralocorticoid Receptors in the Cardiovascular System
John W. Funder
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Use of Aldosterone Antagonists in Heart Failure
Nancy M. Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Corticosteroid receptors, macrophages and cardiovascular disease
Amanda J. Rickard et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2009)
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Uzma F. Mehdi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Change in proteinuria after adding aldosterone Blockers to ACE inhibitors or angiotensin receptor Blockers in CKD: A systematic review
Andrew S. Bomback et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients
E Gross et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Mineralocorticoid receptors: Distribution and activation
JW Funder
HEART FAILURE REVIEWS (2005)
Rapid effects of aldosterone on vascular cells:: clinical implications
R Lösel et al.
STEROIDS (2004)
Aldosterone-induced organ damage: Plasma aldosterone level and inappropriate salt status
A Sato et al.
HYPERTENSION RESEARCH (2004)
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
MH Weinberger et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Share Paper
